Edgewise Therapeutics (EWTX) Stock News and Forecast: Why Shares Rebounded on Dec. 19, 2025—and What Analysts Are Watching Next
December 19, 2025 — Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is back in the spotlight after a sharp one-day rebound that followed a volatile stretch for the clinical-stage biotech. EWTX closed Dec. 19, 2025 at $23.01, up +8.79% on the day after trading between roughly $21.49 and $23.84 on elevated activity. Investing.com For investors, today’s price action is the “symptom.” The bigger story is the “disease biology”: Edgewise is building a pipeline aimed at muscular dystrophies and serious cardiac conditions, with multiple clinical readouts and program updates spaced across late 2025 and beyond. PR Newswire+1 Below is what’s moving the narrative